Skip to main navigation Skip to search Skip to main content

A Phase 3, open-label, randomized 2-arm study comparing the clinical efficacy and safety of niraparib with temozolomide in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma

Project: Research

Project Details

StatusActive
Effective start/end date16/04/2515/04/27

Keywords

  • Clinical Trials
  • IVY-P3-24-021
  • Niraparib

Clinical Trial Phase

  • Phase III (a & b)
  • External Sponsor